DE60223694D1 - Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums - Google Patents

Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums

Info

Publication number
DE60223694D1
DE60223694D1 DE60223694T DE60223694T DE60223694D1 DE 60223694 D1 DE60223694 D1 DE 60223694D1 DE 60223694 T DE60223694 T DE 60223694T DE 60223694 T DE60223694 T DE 60223694T DE 60223694 D1 DE60223694 D1 DE 60223694D1
Authority
DE
Germany
Prior art keywords
plaster
failures
treatment
functional disorders
nail growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60223694T
Other languages
English (en)
Other versions
DE60223694T2 (de
Inventor
Rudy Susilo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trommsdorff GmbH and Co KG
Original Assignee
Trommsdorff GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trommsdorff GmbH and Co KG filed Critical Trommsdorff GmbH and Co KG
Application granted granted Critical
Publication of DE60223694D1 publication Critical patent/DE60223694D1/de
Publication of DE60223694T2 publication Critical patent/DE60223694T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60223694T 2001-09-04 2002-09-04 Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums Expired - Lifetime DE60223694T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01121202 2001-09-04
EP01121202 2001-09-04
PCT/EP2002/009912 WO2003020250A1 (en) 2001-09-04 2002-09-04 Plaster for the treatment of dysfunctions and disorders of nail growth

Publications (2)

Publication Number Publication Date
DE60223694D1 true DE60223694D1 (de) 2008-01-03
DE60223694T2 DE60223694T2 (de) 2008-10-30

Family

ID=8178546

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60223694T Expired - Lifetime DE60223694T2 (de) 2001-09-04 2002-09-04 Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums

Country Status (22)

Country Link
US (1) US20040265362A1 (de)
EP (1) EP1423102B1 (de)
JP (1) JP4806162B2 (de)
KR (1) KR100757611B1 (de)
CN (1) CN1703206A (de)
AU (1) AU2002361825B2 (de)
BR (1) BR0212304A (de)
CA (1) CA2459483C (de)
CY (1) CY1107284T1 (de)
CZ (1) CZ301310B6 (de)
DE (1) DE60223694T2 (de)
DK (1) DK1423102T3 (de)
ES (1) ES2299630T3 (de)
IL (2) IL160550A0 (de)
MX (1) MXPA04001833A (de)
NO (1) NO20040936L (de)
NZ (1) NZ531406A (de)
PL (1) PL205576B1 (de)
PT (1) PT1423102E (de)
RU (1) RU2302857C2 (de)
WO (1) WO2003020250A1 (de)
ZA (1) ZA200401445B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615238B2 (en) * 2001-09-04 2009-11-10 Trommsdorff GmbH & Co. KG Arzneimitttel Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
CZ301310B6 (cs) * 2001-09-04 2010-01-13 Trommsdorff Gmbh & Co. Kg Arzneimittel Náplast
FR2867978B1 (fr) * 2004-03-29 2009-02-20 Galderma Res & Dev Patch d'amorolfine pour le traitement de l'onychomicose
JP4992181B2 (ja) * 2004-12-28 2012-08-08 大正製薬株式会社 外用剤組成物
NZ565049A (en) 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
EP2057988B1 (de) * 2006-08-28 2013-09-11 Hisamitsu Pharmaceutical Co., Inc. Nagelpflaster
WO2008105038A1 (ja) 2007-02-23 2008-09-04 Nichiban Company Limited 抗真菌症用貼付剤
DK3441054T3 (da) * 2007-11-05 2020-11-09 Abigo Medical Ab Indretning til behandling af vaginal svampeinfektion
US8263115B2 (en) * 2008-09-11 2012-09-11 Abigo Medical Ab Method and a product to reduce and treat problems associated with tinea pedis
US10893983B2 (en) 2008-12-03 2021-01-19 Abigo Medical Ab Method for dressing a wound
CN102770123A (zh) * 2009-12-23 2012-11-07 纽沃研究股份有限公司 用于治疗甲癣的高渗透性特比萘芬制剂
WO2011096566A1 (ja) 2010-02-05 2011-08-11 久光製薬株式会社 爪白癬治療用貼付剤
EP2531047A4 (de) 2010-02-05 2014-03-19 Phosphagenics Ltd Träger mit einem nichtneutralisierten tocopherylphosphat
KR101656121B1 (ko) 2010-03-17 2016-09-08 노바리크 게엠베하 안압 증가를 치료하기 위한 약학 조성물
EP2552486B1 (de) 2010-03-30 2020-08-12 Phosphagenics Limited Pflaster für transdermale verabreichung
EP2462921A1 (de) 2010-11-11 2012-06-13 Novaliq GmbH Flüssige pharmazeutische Zusammensetzungen zur Behandlung einer Erkrankung der Hinterseite des Auges
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
RU2483749C2 (ru) * 2011-04-15 2013-06-10 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде биопленки
RU2483748C2 (ru) * 2011-04-15 2013-06-10 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде пластыря
JP6023181B2 (ja) * 2011-05-25 2016-11-09 ノバリック ゲーエムベーハー 爪に投与するための医薬組成物
AU2012260787B2 (en) 2011-05-25 2017-02-02 Dermaliq Therapeutics, Inc. Topical pharmaceutical composition based on semifluorinated alkanes
EP2806886B1 (de) 2012-01-23 2017-03-01 Novaliq GmbH Stabilisierte proteinzusammensetzungen auf basis semifluorierter alkane
CN104755073B (zh) 2012-09-12 2017-12-26 诺瓦利克有限责任公司 半氟化烷烃组合物
CA2883002C (en) 2012-09-12 2019-05-21 Novaliq Gmbh Compositions comprising mixtures of semifluorinated alkanes
CN105555311B (zh) 2013-07-23 2021-10-08 诺瓦利克有限责任公司 稳定的抗体组合物
DE202016008738U1 (de) 2015-09-30 2019-04-09 Novaliq Gmbh Semifluorierte Verbindungen und ihre Zusammensetzungen
JP6642935B2 (ja) 2015-09-30 2020-02-12 ノバリック ゲーエムベーハー 眼投与用の半フッ素化化合物
JP6882321B2 (ja) 2015-12-09 2021-06-02 フォスファージニクス リミテッド 医薬製剤
PL3442480T3 (pl) 2016-06-23 2020-04-30 Novaliq Gmbh Sposób podawania miejscowego
CN109890374A (zh) 2016-09-22 2019-06-14 诺瓦利克有限责任公司 用于治疗睑缘炎的药物组合物
AU2017329983B2 (en) 2016-09-23 2022-05-05 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
AU2017381395A1 (en) 2016-12-21 2019-06-20 Phosphagenics Limited Process
BR112019021917A8 (pt) 2017-04-21 2023-03-21 Novaliq Gmbh Composições de iodo
WO2018206656A1 (en) 2017-05-12 2018-11-15 Novaliq Gmbh Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
BR112020006072A2 (pt) 2017-09-27 2020-10-06 Novaliq Gmbh composições oftalmáticas compreendendo latanoprost para uso no tratamento de doenças oculares
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
WO2019166631A1 (en) 2018-03-02 2019-09-06 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
DE102018115270B4 (de) * 2018-06-26 2022-07-14 Vinederm GmbH Zubereitung als Gel und Pflaster zur topischen Behandlung von Haut- und/oder Nagelerkrankungen
WO2020064556A1 (en) 2018-09-27 2020-04-02 Novaliq Gmbh Topical sunscreen formulation
WO2020074697A1 (en) 2018-10-12 2020-04-16 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
RU2717086C1 (ru) * 2019-01-31 2020-03-18 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Способ получения основы для пластырей и гелей (варианты)
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5181914A (en) * 1988-08-22 1993-01-26 Zook Gerald P Medicating device for nails and adjacent tissue
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
AU4449497A (en) * 1996-10-16 1998-05-11 Ipr-Institute For Pharmaceutical Research Ag New carrier systems
US6727401B1 (en) * 1998-02-12 2004-04-27 Watson Pharmaceuticals, Inc. Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
JP5170486B2 (ja) * 1998-09-10 2013-03-27 バイオイコール ア−ゲー 局所適用性産物
US6303140B1 (en) * 1999-10-13 2001-10-16 Schering-Plough Healthcare Products, Inc. Medicated device for warts, corns, calluses and nails
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
CZ301310B6 (cs) * 2001-09-04 2010-01-13 Trommsdorff Gmbh & Co. Kg Arzneimittel Náplast

Also Published As

Publication number Publication date
DE60223694T2 (de) 2008-10-30
DK1423102T3 (da) 2008-04-14
NO20040936L (no) 2004-06-04
AU2002361825B2 (en) 2007-01-25
NZ531406A (en) 2006-03-31
RU2004106780A (ru) 2005-04-20
JP4806162B2 (ja) 2011-11-02
CN1703206A (zh) 2005-11-30
ZA200401445B (en) 2005-03-10
CY1107284T1 (el) 2012-11-21
PL205576B1 (pl) 2010-05-31
WO2003020250A1 (en) 2003-03-13
CA2459483C (en) 2009-06-23
KR20040031046A (ko) 2004-04-09
RU2302857C2 (ru) 2007-07-20
CZ301310B6 (cs) 2010-01-13
JP2005501885A (ja) 2005-01-20
NO20040936D0 (no) 2004-03-03
PT1423102E (pt) 2008-02-25
ES2299630T3 (es) 2008-06-01
PL367513A1 (en) 2005-02-21
BR0212304A (pt) 2004-10-13
MXPA04001833A (es) 2004-07-08
CA2459483A1 (en) 2003-03-13
EP1423102A1 (de) 2004-06-02
IL160550A (en) 2010-11-30
KR100757611B1 (ko) 2007-09-10
US20040265362A1 (en) 2004-12-30
IL160550A0 (en) 2004-07-25
CZ2004317A3 (cs) 2004-10-13
EP1423102B1 (de) 2007-11-21

Similar Documents

Publication Publication Date Title
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE286028T1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE69922914D1 (de) Stimulationssystem zur Behandlung von Erkrankungen bezüglich des Magenspeiseröhrenreflux
ATE293610T1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
ATE369133T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
DE60234760D1 (de) Phenylindole zur behandlung von hiv
ATE376444T1 (de) Ibandronsäure zur behandlung und vorbeugung von osteoporose
ATE293447T1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60214542D1 (de) Verwendung von cox2 inhibitoren zur behandlung von schizophrenia und des ticks
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60208221D1 (de) Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
ATE369130T1 (de) Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
ATE337787T1 (de) Exemestan zur behandlung von hormonabhängigen störungen
ATE359783T1 (de) Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition